Details of the Drug Reposition

General Information of This Drug (ID: DMLKF3H)

• Drug Name: Prolanta (DMLKF3H)

Information on Drug Reposition of This Drug

3 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Peritoneal cavity cancer	DISBT2JS	2C51.Z	Phase 1	[1]
Ovarian cancer	DISZJHAP	2C73	Phase 1	[1]
Fallopian tube cancer	DISXHWCS	2C74	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)